Clinical Trial Update: A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II single-arm trial of vinflunine as second-line treatment for advanced non-small cell lung cancer has completed enrollment/status. The snippet does not i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Javlor (vinflunine)

Snippet

Sponsor: Veeda Oncology | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED